UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial

JAMA : the journal of the American Medical Association, 1998-12, Vol.280 (24), p.2077

1998

Volltextzugriff (PDF)

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures

The Lancet (British edition), 1996-12, Vol.348 (9041), p.1535-1541

1996

Volltextzugriff (PDF)

Atypical Femur Fractures: Review of Epidemiology, Relationship to Bisphosphonates, Prevention, and Clinical Management

Endocrine reviews, 2019-04, Vol.40 (2), p.333-368

2019

Volltextzugriff (PDF)

Defining Incident Vertebral Deformity: A Prospective Comparison of Several Approaches

Journal of bone and mineral research, 1999-01, Vol.14 (1), p.90-101

1999

Volltextzugriff (PDF)

Factors Associated with Appendicular Bone Mass in Older Women

Annals of internal medicine, 1993-05, Vol.118 (9), p.657

Bauer, Douglas C.

1993

Volltextzugriff (PDF)

Once-Yearly Zoledronic Acid for Treatment of Postmenopausal Osteoporosis

The New England journal of medicine, 2007-05, Vol.356 (18), p.1809-1822

2007

Volltextzugriff (PDF)

Treatment‐Related Changes in Bone Turnover and Fracture Risk Reduction in Clinical Trials of Anti‐Resorptive Drugs: A Meta‐Regression

Journal of bone and mineral research, 2018-04, Vol.33 (4), p.634-642

2018

Volltextzugriff (PDF)

Comparison of BMD Changes and Bone Formation Marker Levels 3 Years After Bisphosphonate Discontinuation: FLEX and HORIZON‐PFT Extension I Trials

Journal of bone and mineral research, 2019-05, Vol.34 (5), p.810-816

2019

Volltextzugriff (PDF)

Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial

JAMA : the journal of the American Medical Association, 2006-12, Vol.296 (24), p.2927

2006

Volltextzugriff (PDF)

Changes in vertebral bone marrow fat and bone mass after gastric bypass surgery: A pilot study

Bone (New York, N.Y.), 2015-05, Vol.74, p.140-145

2015

Volltextzugriff (PDF)

Clinical use of bone densitometry: scientific review

JAMA : the journal of the American Medical Association, 2002-10, Vol.288 (15), p.1889

2002

Volltextzugriff (PDF)

One Year of Alendronate after One Year of Parathyroid Hormone (1–84) for Osteoporosis

The New England journal of medicine, 2005-08, Vol.353 (6), p.555-565

2005

Volltextzugriff (PDF)

The Impact of Paravertebral Block Analgesia on Breast Cancer Survival After Surgery

Regional anesthesia and pain medicine, 2016-11, Vol.41 (6), p.696-703

2016

Volltextzugriff (PDF)

The incidence of osteonecrosis of the jaw in patients receiving 5 milligrams of zoledronic acid: data from the health outcomes and reduced incidence with zoledronic acid once yearly clinical trials program

The Journal of the American Dental Association (1939), 2010-11, Vol.141 (11), p.1365

2010

Volltextzugriff (PDF)

The Effects of Parathyroid Hormone and Alendronate Alone or in Combination in Postmenopausal Osteoporosis

The New England journal of medicine, 2003-09, Vol.349 (13), p.1207-1215

2003

Volltextzugriff (PDF)

Hip Fracture in Women without Osteoporosis

The journal of clinical endocrinology and metabolism, 2005-05, Vol.90 (5), p.2787-2793

2005

Volltextzugriff (PDF)

Efficacy and Safety of a Once-Yearly Intravenous Zoledronic Acid 5 mg for Fracture Prevention in Elderly Postmenopausal Women with Osteoporosis Aged 75 and Older

Journal of the American Geriatrics Society (JAGS), 2010-02, Vol.58 (2), p.292-299

2010

Volltextzugriff (PDF)

Radiological criteria for atypical features of femur fractures: what we can learn when applied in a clinical study setting

Osteoporosis international, 2019-06, Vol.30 (6), p.1287-1295

2019

Volltextzugriff (PDF)

Change in Bone Turnover and Hip, Non‐Spine, and Vertebral Fracture in Alendronate‐Treated Women: The Fracture Intervention Trial

Journal of bone and mineral research, 2004-08, Vol.19 (8), p.1250-1258

2004

Volltextzugriff (PDF)

Improvement in spine bone density and reduction in risk of vertebral fractures during treatment with antiresorptive drugs

The American journal of medicine, 2002-03, Vol.112 (4), p.281-289

2002

Volltextzugriff (PDF)

What Proportion of Incident Radiographic Vertebral Deformities Is Clinically Diagnosed and Vice Versa?

Journal of bone and mineral research, 2005-07, Vol.20 (7), p.1216-1222

2005

Volltextzugriff (PDF)

Pretreatment Levels of Bone Turnover and the Antifracture Efficacy of Alendronate: The Fracture Intervention Trial

Journal of bone and mineral research, 2006-02, Vol.21 (2), p.292-299

2006

Volltextzugriff (PDF)

Relationships Between Bone Mineral Density and Incident Vertebral Fracture Risk with Raloxifene Therapy

Journal of bone and mineral research, 2002-01, Vol.17 (1), p.1-10

2002

Volltextzugriff (PDF)

Serum 25-hydroxyvitamin D is unaffected by multiple freeze-thaw cycles

Clinical chemistry (Baltimore, Md.), 2005, Vol.51 (1), p.258-261

2005

Volltextzugriff (PDF)

SAT0433 Zoledronic Acid Does Not Slow Spinal Radiographic Progression in Those with Radiographic Osteoarthritis

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.828

2016

Volltextzugriff (PDF)

1 – 25 von 448

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(411)
Mit Volltextzugriff
(356)

Publikationsform

Sprache

Englisch
(448)
Japanisch
(73)

Erscheinungsjahr

n.n

Thema

Science & Technology
(407)
Life Sciences & Biomedicine
(354)
Humans
(269)
Biological And Medical Sciences
(217)
Female
(194)
Medical Sciences
(169)
Male
(128)
Middle Aged
(113)
Aged
(107)
Adult
(89)
Animals
(59)
Fundamental And Applied Biological Sciences. Psychology
(53)
Endocrinology & Metabolism
(51)
General & Internal Medicine
(49)
Aged, 80 And Over
(46)
Medicine, General & Internal
(43)
Pharmacology. Drug Treatments
(40)
Risk Factors
(39)
Bone Density
(37)
Osteoporosis
(36)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures

Atypical Femur Fractures: Review of Epidemiology, Relationship to Bisphosphonates, Prevention, and Clinical Management

Defining Incident Vertebral Deformity: A Prospective Comparison of Several Approaches

Factors Associated with Appendicular Bone Mass in Older Women

Once-Yearly Zoledronic Acid for Treatment of Postmenopausal Osteoporosis

Treatment‐Related Changes in Bone Turnover and Fracture Risk Reduction in Clinical Trials of Anti‐Resorptive Drugs: A Meta‐Regression

Comparison of BMD Changes and Bone Formation Marker Levels 3 Years After Bisphosphonate Discontinuation: FLEX and HORIZON‐PFT Extension I Trials

Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial

Changes in vertebral bone marrow fat and bone mass after gastric bypass surgery: A pilot study

Clinical use of bone densitometry: scientific review

One Year of Alendronate after One Year of Parathyroid Hormone (1–84) for Osteoporosis

The Impact of Paravertebral Block Analgesia on Breast Cancer Survival After Surgery

The incidence of osteonecrosis of the jaw in patients receiving 5 milligrams of zoledronic acid: data from the health outcomes and reduced incidence with zoledronic acid once yearly clinical trials program

The Effects of Parathyroid Hormone and Alendronate Alone or in Combination in Postmenopausal Osteoporosis

Hip Fracture in Women without Osteoporosis

Efficacy and Safety of a Once-Yearly Intravenous Zoledronic Acid 5 mg for Fracture Prevention in Elderly Postmenopausal Women with Osteoporosis Aged 75 and Older

Radiological criteria for atypical features of femur fractures: what we can learn when applied in a clinical study setting

Change in Bone Turnover and Hip, Non‐Spine, and Vertebral Fracture in Alendronate‐Treated Women: The Fracture Intervention Trial

Improvement in spine bone density and reduction in risk of vertebral fractures during treatment with antiresorptive drugs

What Proportion of Incident Radiographic Vertebral Deformities Is Clinically Diagnosed and Vice Versa?

Pretreatment Levels of Bone Turnover and the Antifracture Efficacy of Alendronate: The Fracture Intervention Trial

Relationships Between Bone Mineral Density and Incident Vertebral Fracture Risk with Raloxifene Therapy

Serum 25-hydroxyvitamin D is unaffected by multiple freeze-thaw cycles

SAT0433 Zoledronic Acid Does Not Slow Spinal Radiographic Progression in Those with Radiographic Osteoarthritis

Suchergebnisse filtern